177Lu-DOTATATE in neuroendocrine tumors: Real-world evidence of efficacy and safety in a community setting

被引：0
|
作者：
Sassic, Jessica
Farasat, Sadaf
Hermel, David
Sigal, Darren
Xavier, Marin Feldman
机构：
[1] Scripps Mercy Hosp, San Diego, CA USA
[2] Scripps Green Hosp, Scripps Clin, La Jolla, CA USA
[3] Scripps Clin, La Jolla, CA USA
[4] Scripps Clin, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16249
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world efficacy and safety of peptide receptor radionuclide therapy (PRRT) with 177Lu-Dotatate (Lutathera) (LU) in neuroendocrine tumors (NETs)
    Navarro Martin, M.
    Teran Brage, E.
    Campana-Diaz, E.
    Garcia-Talavera, P.
    Reguera Puertas, P.
    Rama-Alonso, S.
    Garijo-Martinez, M. C.
    Felix, L. C.
    Diaz Sanchez, P.
    Vidal Tocino, R.
    Fonseca Sanchez, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S95 - S95
  • [2] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study
    Mitjavila Casanovas, M.
    Pubul, V.
    Bello, P.
    Miguel, B.
    Cano, J.
    Balaguer, D.
    Garcia-Burillo, A.
    Marino Mendez, A.
    Rodeno, E.
    Custodio, A.
    Pineiro, A.
    Garcia-Canamaque, L.
    Castellon, M.
    Orduna, M.
    Carmona-Bayonas, A.
    Jimenez-Fonseca, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S103 - S104
  • [3] Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
    Zidan, Lamiaa
    Iravani, Amir
    Oleinikov, Kira
    Ben-Haim, Simona
    Gross, David J.
    Meirovitz, Amichay
    Maimon, Ophra
    Akhurst, Tim
    Michael, Michael
    Hicks, Rodney J.
    Grozinsky-Glasberg, Simona
    Kong, Grace
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (02) : 218 - 225
  • [4] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Ozdemir, Nuriye Y.
    Arslan, Suheyla A.
    Sendur, Mehmet A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
  • [5] Re-Treatment With 177Lu-DOTATATE in Patients With Neuroendocrine Tumors: Multicenter Real-World Experience
    Navalkissoor, S.
    Essler, M.
    Caplin, M.
    Van Der Zwan, W.
    Wicharz, M.
    De Herder, W.
    Broberg, P.
    Krenning, E.
    PANCREAS, 2021, 50 (03) : 453 - 453
  • [6] Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States
    Delpassand, Ebrahim S.
    Yazdi, Soheil M.
    Ghantoji, Shashank
    Nakasato, Antonio
    Strickland, Corinne
    Nunez, Rodolfo
    Shafie, Afshin
    Cork, Susan
    Byrne, Clare
    Tang, Jackson
    Patel, Jeetvan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (05) : 746 - 752
  • [7] Efficacy of Everolimus Combined with 177Lu-Dotatate in the Treatment of Neuroendocrine Tumors
    Aljubran, Ali
    Badran, Ahmed
    Alrowaily, Mohamed
    Raef, Hussein
    Alzahrani, Ahmed M.
    Almuhaideb, Ahmed
    Almanea, Hadeel
    El-Dali, Abdelmoneim
    Tuli, Mahmoud
    Bazarbashi, Shouki
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2024, 39 (02) : 164 - 168
  • [8] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [9] Early prediction of the efficacy of 177Lu-DOTATATE in patients with metastatic neuroendocrine tumors
    Bando-Delaunay, A.
    de Rycke, O.
    Hentic, O.
    Leclerc, P.
    Allouch, A.
    Cros, J.
    Rebours, V
    Ruszniewski, P.
    Lebtahi, R.
    de Mestier, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 176 - 176
  • [10] Toxicity evaluation of 177Lu-DOTATATE for advanced neuroendocrine tumors
    Bonilla Plaza, J.
    Martinez Lorca, A.
    Navarro Martinez, T.
    Ajuria Illarramendi, O.
    Lopez Villar, I.
    Azpeitia Hernandez, P.
    Gutierrez Guerrero, M.
    Paredes Rodriguez, P.
    Orduna Diez, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S471 - S471
12345